Biological activity of synthesized 5-{1-[(4-chlorophenyl)sulfonyl]piperidin-4- yl}-2-mercapto-1,3,4-oxadiazole derivatives demonstrated by in silico and BSA binding studies. Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 56, p. e18092, 2020. DOI: 10.1590/s2175-97902020000118092. Disponível em: https://periodicos.usp.br/bjps/article/view/182524.. Acesso em: 10 jun. 2024.